One in Six Billion
Avsnitt

Series 4 episode 6: Hannah Robinson and Nick Thomas. Taking immunotherapy to delay adult-onset Type 1 diabetes

One in Six Billion
Dela

Hannah Robinson was the first adult in the UK to be given the new immunotherapy drug Teplizumab, which aims to slow down the development of type 1 diabetes. Hannah had multiple pancreatic autoantibodies and hence is on the path to developing Type 1 diabetes (Series 4 Episode 3). Her consultant, Nick Thomas, arranged 14 consecutive daily hospital visits for her to receive the drug through a drip. 

Send a text

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Andrew Hattersley and Maggie Shepherd. Innehållet i podden är skapat av Andrew Hattersley and Maggie Shepherd och inte av, eller tillsammans med, Poddtoppen.